Insulin glargine provides greater improvements in glycaemic control vs. intensifying lifestyle management for people with type 2 diabetes treated with OADs and 7–8% A1c levels. The TULIP study - Blicklé, J F; Hancu, N; Piletic, M; Profozic, V; Shestakova, M; Dain, M P; Jacqueminet, S; Grimaldi, A (Diabetes Obes Metab, 2009)